Overview

Safety Study of Flufirvitide-3 Nasal Spray in Healthy Subjects

Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and pharmacokinetic profile of flufirvitide-3 nasal spray in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Autoimmune Technologies, LLC